Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Strategic Master's Award - Pandemic Preparedness and Health Emergencies

McMaster University

$17,500.00

De-novo design of antibiotics targeting Acinetobacter baumannii using chemical language models

FY 2023-24

Summary
The antimicrobial resistance (AMR) crisis is anticipated to result in 10 million deaths annually by 2050. Among the largest bacterial threats indicated by the World Health Organization is Acinetobacter baumannii, a nosocomial pathogen linked with over 300,000 deaths in 2019 alone. The threat of A. baumannii arises from its remarkable capacity to uptake extracellular DNA, facilitating the rapid acquisition of antibiotic resistance determinants. Combined with the lean antibiotic pipeline, this situation leaves us with few treatment alternatives moving forward. Amidst these challenges, generative artificial intelligence (GAI) has emerged as an increasingly applied tool in drug design and presents a promising avenue to design structurally and functionally novel antibiotics. This project aims to develop a GAI algorithm for the design of antibiotic compounds targeting A. baumannii. We will train a GAI algorithm using an in-house chemical inhibition dataset. This dataset comprises both active and non-active molecules against A. baumannii, enabling the algorithm to learn what molecular features are associated with favorable activity and which are not. Once trained, the algorithm will be capable of rapidly generating structurally novel compounds that are heavily enriched with antibiotic properties against A. baumannii. Molecules exhibiting favorable properties in silico will be synthesized and undergo wet-lab testing to validate their efficacy. Those demonstrating promising activity will then be prioritized for further in-depth studies, aiming to assess their clinical viability. Ultimately, as A. baumannii continues to pose an escalating global threat, this project will play a pivotal role in advancing antibiotic discovery, and increasing our currently limited repertoire of effective antibiotics.
Program
CIHR Strategic Master's Award - Pandemic Preparedness and Health Emergencies
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
498796
Name
Alexander Jeremie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Master's Award: Strategic Master's Award
Projecttitle
De-novo design of antibiotics targeting Acinetobacter baumannii using chemical language models
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
CIHR Strategic Master's Award - Pandemic Preparedness and Health Emergencies
Keyworddelim
Acinetobacter Baumannii; Antibiotic Resistance; Antibiotics; Artificial Intelligence; Chemistry; Drug Discovery; Language Models; Machine Learning
Abstract
The antimicrobial resistance (AMR) crisis is anticipated to result in 10 million deaths annually by 2050. Among the largest bacterial threats indicated by the World Health Organization is Acinetobacter baumannii, a nosocomial pathogen linked with over 300,000 deaths in 2019 alone. The threat of A. baumannii arises from its remarkable capacity to uptake extracellular DNA, facilitating the rapid acquisition of antibiotic resistance determinants. Combined with the lean antibiotic pipeline, this situation leaves us with few treatment alternatives moving forward. Amidst these challenges, generative artificial intelligence (GAI) has emerged as an increasingly applied tool in drug design and presents a promising avenue to design structurally and functionally novel antibiotics. This project aims to develop a GAI algorithm for the design of antibiotic compounds targeting A. baumannii. We will train a GAI algorithm using an in-house chemical inhibition dataset. This dataset comprises both active and non-active molecules against A. baumannii, enabling the algorithm to learn what molecular features are associated with favorable activity and which are not. Once trained, the algorithm will be capable of rapidly generating structurally novel compounds that are heavily enriched with antibiotic properties against A. baumannii. Molecules exhibiting favorable properties in silico will be synthesized and undergo wet-lab testing to validate their efficacy. Those demonstrating promising activity will then be prioritized for further in-depth studies, aiming to assess their clinical viability. Ultimately, as A. baumannii continues to pose an escalating global threat, this project will play a pivotal role in advancing antibiotic discovery, and increasing our currently limited repertoire of effective antibiotics.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alexander, Jeremie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~